- $9.60m
- $9.54m
- $3.93m
Brief: Jupiter Wellness Inc Commences Trading On Upstream Under JUPW
Brief: Srm Entertainment Files S-1 Registration For Spin-Off From Jupiter Wellness
Brief: Jupiter Wellness Initiates Clinical Trial For Potential New Treatment For Tinnitus
Brief: Jupiter Wellness Announces Application For Dual Listing On Upstream
Brief: Jupiter Wellness Announces Notice Of Allowance For Minoxidil Adjuvant Therapies U.S. Patent
Brief: Jupiter Wellness Inc Is Developing RJ-101 A New Product With A Novel Mechanism Of Action In Women's Sexual Wellness Category
Brief: Jupiter Wellness Says Communicating With Listing Qualifications Department Of Nasdaq Regarding Issue Of Non-Compliance
Brief: Jupiter Wellness Expands Distribution In Asia And The Middle East With Newly Acquired Minoxidil (Rogaine) And Photosil Products
Brief: Jupiter Wellness- On June 23, Co Got Deficiency Letter From Nasdaq Regarding Minimum Bid Requirement
Brief: Jupiter Wellness Inc Announces Retirement Of About 10% Of Its Outstanding Shares
Brief: Jupiter Wellness Inc Files Prospectus Related To Offering Of Up To 6.8 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Jupiter Wellness To Offer Clinical Research Services With Acquisition Of Ascent Clinical Research
Brief: Jupiter Wellness Enters Into Loan Agreement
U.S. STOCKS ON THE MOVE-Tesla, Nine Energy, Mandiant
Brief: Jupiter Wellness Inc - Next Frontier Pharmaceuticals Terminated The Purchase Agreement
Brief: Jupiter Wellness Inc - Completed Recruitment For Its Clinical Trial Of Jw-200 For Treatment Of Actinic Keratosis
Brief: Jupiter Wellness Inc Says Board Approved A $5 Mln Share Buyback Program
Brief: Jupiter Wellness Inc To Dividend SRM Entertainment Subsidiary To Its Stockholders
Brief: Jupiter Wellness’ Merger Partner Next Frontier Pharmaceuticals, Inc. Enters Psychedelic Drug Development And API Market